Hemispherian Raises The First Tranche Of A Series A To Fund The Development Of Its Novel Cancer Therapeutics
Round Type
Series A
OsloBiotechnologyHealth CareScience And EngineeringPrivacy And SecurityInvestors
Description
Hemispherian AS ("Hemispherian" or the "Company"), a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics targeting the DNA damage response, is delighted to announce the closure of the first tranche of its series A1 financing round. The round raised NOK 30M (USD 2.9M). The proceeds will support the company's drug development activities, expand its preclinical pipeline and advance its lead therapeutic compounds towards clinical development.
Quick answer
Hemispherian AS raised an undisclosed amount in a Series A round, dated November 24, 2022. Investors: The Dutch Investment Firm. Hemispherian AS is based in Oslo, Norway.
- How much did Hemispherian AS raise?
- Hemispherian AS raised an undisclosed amount in a Series A round on November 24, 2022.
- Who invested in Hemispherian AS?
- The Dutch Investment Firm is named as investors in this round.
- What does Hemispherian AS do?
- Hemispherian is an innovative pharmaceutical company focused on developing a novel class of small molecule drugs (GLIX).
- Where is Hemispherian AS based and how big is it?
- Hemispherian AS is based in Oslo, Norway.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Privacy And Security around the same time
Companies in the same sectors as Hemispherian AS that raised within 45 days of this round, from Fundz verified event records.
- Aspen Neuroscience raised $40M (Debt Financing) on December 22, 2022.
- Cardurion Pharmaceuticals raised $18M on December 16, 2022.
- Trait Biosciences Inc. raised $230K (Series A) on November 16, 2022.
- Appili Therapeutics Inc. raised $14M (Funding Round) on November 14, 2022.
- Viome raised $67M (Series C) on October 18, 2022.
- Variantyx raised $20M on October 18, 2022.
Who to call at Hemispherian AS, and when
A new round usually means Hemispherian AS is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Hemispherian AS raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Hemispherian AS, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Hemispherian AS. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Hemispherian AS raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansHemispherian AS raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.